United States Hemato-Oncology Testing Market Set to Reach $620M by 2031 - Precision Diagnostics Driving Growth | Top Companies are F. Hoffman-La Roche Ltd., Abbott Laboratories, Qiagen N.V.

The Global Hemato Oncology Testing Market reached USD 280 million in 2022 and is projected to witness lucrative growth by reaching up to USD 620 million by 2031. The market is growing at a CAGR of 4.8% during the forecast period (2024-2031).

Hemato-oncology testing encompasses diagnostic and monitoring tests used for blood cancers, including leukemia, lymphoma, and multiple myeloma. These tests involve flow cytometry, molecular diagnostics, cytogenetics, immunohistochemistry, and next-generation sequencing (NGS) to detect genetic mutations, monitor disease progression, and guide treatment decisions. The market is expanding due to rising prevalence of hematologic cancers, increasing adoption of precision medicine, and growing demand for early and accurate diagnostics.

📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Hemato Oncology Testing Market Landscape:- https://datamintelligence.com/download-sample/hemato-oncology-testing-market?rk

☛ Hemato Oncology Testing Market Recent Developments 2025:

United States: Recent Industry Developments

✅ In August 2025, Freenome expanded its liquid biopsy and hematologic cancer testing platforms in the U.S., supporting early detection and treatment monitoring.

✅ In July 2025, Foundation Medicine launched advanced molecular profiling tests for hematologic malignancies, integrating genomic and transcriptomic analyses for personalized therapy guidance.

✅ In June 2025, Thermo Fisher Scientific partnered with U.S. hospitals to deploy next-generation sequencing (NGS) panels for blood cancer diagnostics and clinical trials.

Europe: Recent Industry Developments

✅ In July 2025, QIAGEN expanded its hematology and oncology testing solutions across European laboratories, including comprehensive NGS and PCR-based assays.

✅ In June 2025, Eurofins Scientific launched specialized blood cancer diagnostic panels in EU markets, improving early detection and treatment monitoring.

✅ In May 2025, SOPHiA Genetics partnered with European clinics to implement AI-driven hemato-oncology testing, enhancing diagnostic accuracy and clinical decision support.

Japan: Recent Industry Developments

✅ In July 2025, Sysmex Corporation launched advanced hemato-oncology testing platforms for Japanese hospitals and diagnostic centers, emphasizing precision and automation.

✅ In June 2025, Fujirebio expanded its biomarker-based testing solutions for leukemia, lymphoma, and multiple myeloma in Japan.

✅ In May 2025, Takara Bio Inc. partnered with academic institutions to deploy next-generation sequencing and cytogenetic testing for hematologic cancers.

☛ Hemato Oncology Testing Market Trends:

Technological Advancements: Innovations in NGS, multiplex assays, digital pathology, and AI-powered diagnostic platforms are improving test accuracy, turnaround times, and personalized treatment planning.

Rising Cancer Incidence: The increasing burden of hematologic malignancies worldwide is driving demand for early detection, prognosis, and treatment monitoring tests.

Integration with Personalized Medicine: Hemato-oncology testing is increasingly used in tailoring targeted therapies, immunotherapies, and combination treatments, enhancing treatment efficacy and patient outcomes.

Regional Insights: North America leads the market due to advanced healthcare infrastructure, high adoption of molecular diagnostics, and strong R&D initiatives. Asia-Pacific is emerging as a high-growth region with increasing healthcare investment, awareness, and diagnostic adoption.

Challenges: High costs of advanced testing platforms, limited availability in developing regions, and complex regulatory requirements may restrict widespread adoption.

Strategic Initiatives: Companies are focusing on R&D, collaborations with hospitals and research institutions, and development of integrated diagnostic platforms to expand market reach and enhance test capabilities.

☛ Hemato Oncology Testing Market Competitve Landscape:

F. Hoffman-La Roche Ltd., Abbott Laboratories, Qiagen N.V., Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., ICON PLC, Archerdx, Inc., Invivoscribe, Inc., and Adaptive Biotechnologies.

Research Methodology

We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/hemato-oncology-testing-market

☛ Segment Covered in the Hemato Oncology Testing Market:

By Type of Product: Service (Instruments, Reagents: Consumables, Services)

By Technology: PCR | IHC | NGS | Cytogenetics | Others

By Cancer Type: Leukemia | Acute Myeloid Leukemia | Acute Lymphocytic Leukemia | Lymphoma | Multiple Myelomas | Others

By End-User: Clinical Laboratories | Hospitals | Academic: Research Institutes | Others

☛ This Report Includes:

✔ Comprehensive go-to-market strategies with actionable insights.

✔ Unbiased evaluation of overall market performance.

✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.

✔ Tailored regional and country-level reports with detailed localized analysis available on request.

✔ Identification of niche segments and high-growth regions presenting strong opportunities.

✔ Accurate regional forecasts using both top-down and bottom-up approaches.

📌 Get Corporate Access to Live Hemato Oncology Testing Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=hemato-oncology-testing-market

☛ Regional Analysis for Hemato Oncology Testing Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

☛ Frequently asked questions:

➠ What is the global sales, production, consumption, import, and export value of the Hemato Oncology Testing Market?
➠ Who are the key global manufacturers, and what is their operational performance?
➠ What are the major opportunities and threats in the global Hemato Oncology Testing Market?
➠ Which product types or end-users show the most growth potential and market share?
➠ What challenges and constraints are impacting the Hemato Oncology Testing Market?
➠ What sales, marketing, and distribution channels are used globally?

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.